![Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer]()
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerAwasthi, N.; Zhang, C.; Schwarz, A. M.; Hinz, S.; Wang, C.; Williams, N. S.; Schwarz, M. A.; Schwarz, R. E. · Carcinogenesis · 2013